BIO-TECHNE Corp — Director's Dealing 2023

Apr 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-04-19

Reporting Person: Nusse Roeland (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-19	Common Stock	G	377	—	Disposed	28811	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$21.85	2023-10-30	Common Stock (16000)	16000	Direct
Stock Options (Right to Buy)	$22.95	2024-10-30	Common Stock (16000)	16000	Direct
Stock Options (Right to Buy)	$21.84	2025-10-28	Common Stock (17040)	17040	Direct
Stock Options (Right to Buy)	$25.30	2026-10-27	Common Stock (15940)	15940	Direct
Stock Options (Right to Buy)	$31.26	2027-10-26	Common Stock (12500)	12500	Direct
Stock Options (Right to Buy)	$44.96	2028-10-25	Commo Stock (7592)	7592	Direct
Stock Options (Right to Buy)	$50.41	2029-10-24	Common Stock (8044)	8044	Direct
Stock Options (Right to Buy)	$63.92	2030-10-29	Common Stock (6028)	6028	Direct
Stock Options (Right to Buy)	$128.81	2031-10-28	Common Stock (2532)	2532	Direct
Stock Options (Right to Buy)	$73.94	2032-10-27	Common Stock (3460)	3460	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.